LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,643 | +65.4% | 12,711 | +99.0% | 0.01% | +100.0% |
| Q2 2023 | $460,431 | +879.6% | 6,386 | +1319.1% | 0.00% | – |
| Q4 2019 | $47,000 | -19.0% | 450 | -22.1% | 0.00% | -100.0% |
| Q3 2019 | $58,000 | +56.8% | 578 | +80.6% | 0.00% | – |
| Q2 2019 | $37,000 | -2.6% | 320 | +6.7% | 0.00% | – |
| Q1 2019 | $38,000 | -97.7% | 300 | -97.5% | 0.00% | -100.0% |
| Q4 2018 | $1,628,000 | +16180.0% | 12,000 | +17042.9% | 0.02% | – |
| Q4 2017 | $10,000 | +25.0% | 70 | +12.9% | 0.00% | – |
| Q3 2017 | $8,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |